ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study

Li, Xinyan; Chen, Xi; Yuan, Yixiao; Zhai, RuiQing; Cho, William C.*; Jiang, Xiulin*哈尔滨医科大学; 中国科学院研究生院; 中国科学院
Frontiers in Oncology2022-5-30DOI: 10.3389/fonc.2022.916947
2被引7阅读
引用收藏
分享

摘要

Family with sequence similarity 72B (FAM72B) has been characterized in the regulation of neuronal development. Nevertheless, the prognostic value of FAM72B expression and its function in the immune microenvironment of lung adenocarcinoma (LUAD) currently remains elusive. In this study, by adopting bioinformatics methodology and experimental verification, we found that FAM72B was upregulated in lung cancer tissues and cell lines, and a higher FAM72B level predicted an unfavorable clinical outcome in LUAD patients. The knockdown of FAM72B significantly inhibited cell proliferation, cell migration, and induced cell apoptosis in LUAD. The receiver operating characteristic curve suggested that FAM72B had a high predictive accuracy for the outcomes of LUAD. Kyoto Encyclopedia of Genes and Genomes and Gene Set Enrichment Analyses confirmed that FAM72B-related genes were involved in cell proliferation and immune-response signaling pathway. Moreover, upregulated FAM72B expression was significantly associated with immune cell infiltration in the LUAD tumor microenvironment. Meanwhile, a potential ceRNA network was constructed to identify the lncRNA-AL360270.2/TMPO-AS1/AC125807.2/has-let-7a/7b/7c/7e/7f/FAM72B regulatory axis that regulates FAM72B overexpression in LUAD and is associated with a poor prognosis. We also confirmed that AL360270.2, TMPO-AS1, and AC125807.2 were significantly upregulated in LUAD cell lines than in human bronchial epithelial cells. In conclusion, FAM72B may serve as a novel biomarker in predicting the clinical prognosis and immune status for lung adenocarcinoma.

学科与关键词

关键词
FAM72Blung adenocarcinomaprognosis biomarkerimmune infiltrationceRNA
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-05-30
卷期
第 12 卷
页码
916947
DOI
10.3389/fonc.2022.916947
期刊等级
3区
成果收录
SCIE
资助标注
National Nature Science Foundation of China [82160512, 30960398, 81460174, 81360126]; Yunnan Applied Basic Research Projects [2017FE467, 2018FE001]; Yunnan Provincial Science and Technology Department, Kunming Medical University [2020001AY070001-117]; First People's Hospital of Yunnan Province Clinical Medicine Center [2021LCZXXF-XZ03]

作者

  • L

    Li, Xinyan (第一作者)

    shanghai univ tradit chinese med

  • C

    Chen, Xi

    2 · kunming med univ

查看全部 6 位作者收起作者
  • Y

    Yuan, Yixiao

    kunming med univ

  • Z

    Zhai, RuiQing

    harbin med univ

  • C

    Cho, William C. (通讯)

  • J

    Jiang, Xiulin (通讯)

    chinese acad sci · kunming inst zool · univ chinese acad sci

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417